A novel oral medicine working as a chelator & based on EDTA to reduce iron overload of Thal.M children (No. 100,000+ in India) is described. It is to be taken in very small dose. The proposed formulation has small amounts of catalysts to increase the efficiency and trace elements to boost the vital energy of the child. It is formulated so as to be more acceptable to the children. The formulation has benefits over the existing 3 types of Molecules. Cost wise it is approx Rs 50 per month, Which is 5% of the lowest costing medicine (kelfer) and 03% of the costliest(desferral) It can be afforded by all.
